[Polymorphism of acetylation and oxidation phenotypes and the risk of neoplasms--pharmacogenetic approach to the epidemiology of neoplasms].
In recent years more and more attention has been devoted to the relation between the appearance of neoplasms and the polymorphism of the acetylation and oxidation phenotypes. The work is an attempt at presenting modern views and statements on that subject.